NEW DELHI - Consumer inflation and industrial output data on Wednesday will likely offer little evidence of a respite from high inflation and weak economic growth before a general election that begins next month.
Tue, Mar 11 2014
NEW DELHI - India has put on ice plans to join major emerging market bond indexes that would require removal of restrictions on capital inflows, two sources said, taking a decision that knocked the rupee, but showed balance of payments concerns were easing.
NEW DELHI - Metals producer Sesa Sterlite said it may have to cut jobs if the Supreme Court sets a limit on the amount of iron ore it can mine in Goa when and if it allows mining to restart in what used to be the country's top exporter.
MUMBAI - A group of investors in Maruti Suzuki Ltd ratcheted up pressure on India's top carmaker to abandon a plan for its Japanese parent to build a new plant to make cars for the Indian firm, saying it would hurt shareholders.
NEW YORK/SAN FRANCISCO - Janet Yellen's first policy-setting meeting as chair of the U.S. Federal Reserve will focus on how to finesse a rewriting of the central bank's promise to keep interest rates low without roiling financial markets.
NEW YORK/LONDON - Gold rose on Tuesday as fears of a slowdown in Chinese economic activity and worries about an escalating crisis in Ukraine boosted demand for bullion.
NEW DELHI - India has to cut its Iranian oil imports by nearly two-thirds from the first quarter after the United States asked it to hold the shipments at end-2013 levels, in keeping with the nuclear deal easing sanctions on Tehran, Indian government sources said.
NEW YORK - U.S. stocks fell on Tuesday, with selling picking up late in the session, as investors cashed in some of the recent market gains, but the S&P 500 finished less than 1 percent away from a record high set last week.
NEW DELHI - Merchandise exports fell for the first time in eight months in February, signalling the country may miss its annual overseas sales target for the second straight year, data released on Tuesday showed.
MUMBAI/LONDON - Drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States.